Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Biotech
AZ pauses $271M UK expansion as British backtrack continues
The investment was meant to fund a facility near AstraZeneca’s Cambridge headquarters that would have employed around 1,000 people.
Darren Incorvaia
Sep 12, 2025 2:44pm
Eli Lilly reconsiders UK biotech incubator
Sep 12, 2025 12:09pm
Sponsored
Carl Sailer on AI, market trends, and strategic planning in biotech
Oct 28, 2024 8:00pm
Galimedix’s oral Alzheimer’s candidate clears ph. 1 safety test
Sep 12, 2025 11:11am
Sponsored
Guidehouse’s Karla Anderson shares top tips for successful biotech commercialization
Oct 28, 2024 8:00am
Takeda taps longtime Lilly exec as US head—Chutes & Ladders
Sep 12, 2025 8:30am